Stocksigma LogoStocksigma Logo

Suraksha Diagnostic Delivers Robust Q2 and H1 FY27 Results Driven by Margin Expansion

Suraksha Diagnostic reported strong Q2 FY27 performance with total income rising 26% YoY to ₹1,005.75 million, EBITDA jumping 45% YoY to ₹363.17 million

Suraksha Diagnostic Delivers Robust Q2 and H1 FY27 Results Driven by Margin Expansion

Suraksha Diagnostic Ltd · Press Release · 13 Nov 2026, 12:16 am

Suraksha Diagnostic Delivers Robust Q2 and H1 FY27 Results Driven by Margin Expansion Suraksha Diagnostic reported strong Q2 FY27 performance with total income rising 26% YoY to ₹1,005.75 million, EBITDA jumping 45% YoY to ₹363.17 million (margin expanding 500 bps to 36.7%), and PAT surging 69% YoY to ₹149.50 million. For H1 FY27, total income grew 24% YoY to ₹1,893.09 million and PAT rose 54% YoY to ₹277.96 million. Per corrected operational metrics, Q2 total tests grew 9% YoY to 2.40 million, while average revenue per test increased 15% YoY to ₹412, supported by network expansion of five new centres.

Original exchange filing (PDF)

More announcements from Suraksha Diagnostic Ltd

All Suraksha Diagnostic Ltd announcements